₹287.2
▼ -12.31 -4.11%
17 Jul 2026
NSE Listed
ASM 1Tarsons Products Limited (TARSONS)
20-day avg volume: 6.7L shares
- Healthy return on equity of 225.7%.
- Company is almost debt-free.
- Revenue fell 23% YoY.
- Stock trades at a high P/E of 379.
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹85 Cr | ₹99 Cr | ₹96 Cr | ₹113 Cr | ₹91 Cr | ₹102 Cr | ₹108 Cr | ₹121 Cr |
| EBITDA | ₹11 Cr | ₹20 Cr | ₹13 Cr | ₹21 Cr | ₹8 Cr | ₹11 Cr | ₹15 Cr | ₹12 Cr |
| Net Profit | ₹4 Cr | ₹10 Cr | ₹5 Cr | ₹10 Cr | ₹2 Cr | ₹3 Cr | ₹5 Cr | ₹4 Cr |
| EPS | — | — | — | — | — | — | — | — |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue | ₹180 Cr | ₹234 Cr | ₹309 Cr | ₹308 Cr | ₹408 Cr |
| EBITDA | ₹59 Cr | ₹95 Cr | ₹139 Cr | ₹71 Cr | ₹64 Cr |
| Net Profit | ₹41 Cr | ₹69 Cr | ₹101 Cr | ₹43 Cr | ₹30 Cr |
| EPS | 7.94 | 13.43 | 19.46 | 8.01 | 5.6 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Total Assets | ₹249 Cr | ₹296 Cr | ₹544 Cr | ₹972 Cr | ₹1,080 Cr | ₹1,186 Cr |
| Total Liabilities | ₹51 Cr | ₹52 Cr | ₹54 Cr | ₹359 Cr | ₹450 Cr | ₹551 Cr |
| Equity | ₹198 Cr | ₹244 Cr | ₹490 Cr | ₹613 Cr | ₹630 Cr | ₹635 Cr |
| Total Debt | ₹6 Cr | — | — | — | — | ₹393 Cr |
| Metric | Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | ₹92 Cr | ₹117 Cr | ₹121 Cr | ₹130 Cr | ₹118 Cr |
| Investing | ₹-64 Cr | ₹-138 Cr | ₹-285 Cr | ₹-145 Cr | ₹-130 Cr |
| Financing | ₹-27 Cr | ₹130 Cr | ₹136 Cr | ₹39 Cr | ₹9 Cr |
| Free Cash Flow | ₹92 Cr | ₹117 Cr | ₹121 Cr | ₹130 Cr | ₹-7 Cr |
Healthcare · Miscellaneous
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers bottles and carboys; boxes and racks; cell cell culture ware, centrifuge ware, clamps and stands, cryoware, desiccator, tubings and connectors, filtration, genomics and PCR consumables, laboratory equipment and utilities, liquid handling consumables and reusables, magnetic stirrer bar, pp storage plates, sampling aids, vials and tubes, and volumetric reusables. It also provides general lab ware products. Its products are used in molecular biology, cell culture, genomics, proteomics, and immunology. Tarsons Products Limited was incorporated in 1983 and is headquartered in Kolkata, India.
www.tarsons.com ↗As of 2026-03-31
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% | 47.3% |
| FIIs | 8.6% | 7.8% | 6.8% | 8.2% | 8% | 8% | 7.5% | 9.5% | 9.1% | 5.8% | 2.5% | 0.9% |
| DIIs | 7.4% | 3.2% | 2.6% | 0.2% | 0.1% | 0.2% | 0.5% | 0.3% | 0% | 0.1% | 0% | 0.2% |
| Public | 36.7% | 41.7% | 43.3% | 44.4% | 44.6% | 44.4% | 44.7% | 42.9% | 43.5% | 46.8% | 50.2% | 51.6% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,07,440 | 1,08,236 | 1,07,564 | 1,02,866 | 1,05,330 | 99,586 | 96,927 | 93,417 | 90,891 | 88,966 | 87,336 | 84,093 |
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sanjive Sehgal | Shareholding of Promoter and Promoter Group | 27% | 1.44 Cr |
| Clear Vision Investment Holdings Pte Limited | Public Shareholding | 23.4% | 1.25 Cr |
| Aryan Sehgal | Shareholding of Promoter and Promoter Group | 20.3% | 1.08 Cr |
| Gracious Advisors Llp | Public Shareholding | 3.2% | 16,76,000 |
| Anu Nagrath | Shareholding of Promoter and Promoter Group | 0% | 2,915 |
| Jyoti Likhari | Shareholding of Promoter and Promoter Group | 0% | 2,915 |
| Anshu Kapur | Shareholding of Promoter and Promoter Group | 0% | 4,615 |
| Neeta Arora | Shareholding of Promoter and Promoter Group | 0% | 2,915 |
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Anu Nagrath | 0 | 0% | 2026-03-31 |
| Jyoti Likhari | 0 | 0% | 2026-03-31 |
| Anshu Kapur | 0 | 0% | 2026-03-31 |
| Neeta Arora | 0 | 0% | 2026-03-31 |
| Sanjive Sehgal | 0 | 0% | 2026-03-31 |
| Aryan Sehgal | 0 | 0% | 2026-03-31 |
| Clear Vision Investment Holdings Pte Limited | 0 | 0% | 2026-03-31 |
| Gracious Advisors Llp | 0 | 0% | 2026-03-31 |
| Sanjive Sehgal | 0 | 0% | 2025-12-31 |
| Aryan Sehgal | 0 | 0% | 2025-12-31 |
| Anshu Kapur | 0 | 0% | 2025-12-31 |
| Anu Nagrath | 0 | 0% | 2025-12-31 |
| Name | Designation | Year |
|---|---|---|
| Sanjive Sehgal | Chairman / Executive Director / M D / Promoter | 2025 |
| Aryan Sehgal | Whole-time Director | 2025 |
| Viresh Oberai | Independent Non Exe. Director | 2025 |
| SURESH ESHWARA PRABHALA | Non-Exec & Non-Independent Dir | 2025 |
| Divya Momaya | Independent Non Exe. Director | 2025 |
| Monjori Mitra | Independent Non Exe. Director | 2025 |
| Ramanathan Subramanian Arun Kumar | Independent Non Exe. Director | 2025 |
| SANTOSH KUMAR AGARWAL | CFO / Company Secretary / Compliance Officer | 2025 |
| Vinesh Kriplani | Additional Director | 2025 |
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing and selling of plasti | ₹0 Cr | — |
| Region | Revenue | Share |
|---|---|---|
| India | ₹213 Cr | 68% |
| Outside India | ₹100 Cr | 32% |
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹2 | 20 | 11 | 11 |
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 204 | 0 | 0 | 9 | 0 | 213 |
| 2025 | 196 | 0 | 0 | 0 | 0 | 196 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
3 disclosure(s)
📍 Martin Burn Business Park, R No 902 BP-3 Salt Lake Sec-V, Kolkata, West Bengal, 700091
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search